SuceenaAlexander IndiaChristian Medical College Vellore

Suceena Alexander is a consultant Nephrologist and Indian Alliance Senior Fellow in Christian Medical College Vellore since 2010. She is a clinician scientist and has PhD on IgA Nephropathy. She is a member of many Nephrology Societies. Research interests encompass renal fibrosis, immune-mediated renal disease, in particular IgA-nephropathy, renal genetics, as well as CKD. She has established the first South-Asian prospective longitudinal IgA nephropathy cohort (GRACE-IgANI) since 2015 and an institutional Prospective Glomerulonephritis Registry and Bio-Repository since 2019. She is also involved in glomerulonephritis clinical trials and in CKD research.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/b0eb685d828dbc21a2970fa55b7e4eef.jpeg

First name

Suceena

Last name

Alexander

Institution

Country

India

Sunday, February 9, 2025

Time	Session

9 a.m. 10:30 a.m.	HIT! High Impact Clinical Trials – Why and How HIT2 DavidWheeler Chair United KingdomUniversity College London Winston Wing ShingFung Chair Hong Kong, ChinaPrince of Wales Hospital, Hong Kong What Have We Learned From CONVINCE? HIT2-1 PeterBlankestijn Oral Abstract Presenter NetherlandsUniversity Medical Center Utrecht Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease HIT2-2 VladoPerkovic Oral Abstract Presenter AustraliaUniversity of New South Wales, Sydney, Australia A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) HIT2-3 Jonathan Barret Oral Abstract Presenter jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease HIT2-4 KateBramham Oral Abstract Presenter United KingdomKing's College London Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage HIT2-5 Selvin Sundar RajMani Oral Abstract Presenter IndiaAssociate Professor in Nephrology, Christian Medical College, Vellore, India SuceenaAlexander Oral Abstract Presenter IndiaChristian Medical College Vellore Brahmkamal Hall - Plenary Hall

Time

Session

9 a.m.

10:30 a.m.

HIT! High Impact Clinical Trials – Why and How

DavidWheeler Chair United KingdomUniversity College London

Winston Wing ShingFung Chair Hong Kong, ChinaPrince of Wales Hospital, Hong Kong

What Have We Learned From CONVINCE?

HIT2-1

PeterBlankestijn Oral Abstract Presenter NetherlandsUniversity Medical Center Utrecht
Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease

HIT2-2

VladoPerkovic Oral Abstract Presenter AustraliaUniversity of New South Wales, Sydney, Australia
A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)

HIT2-3

Jonathan Barret Oral Abstract Presenter jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK
Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease

HIT2-4

KateBramham Oral Abstract Presenter United KingdomKing's College London
Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage

HIT2-5

Selvin Sundar RajMani Oral Abstract Presenter IndiaAssociate Professor in Nephrology, Christian Medical College, Vellore, India

SuceenaAlexander Oral Abstract Presenter IndiaChristian Medical College Vellore

Brahmkamal Hall - Plenary Hall

Thursday, February 6, 2025

Time	Session

9 a.m. 11 a.m.	Glomerular Disease Course: A Case-based Approach to Renal Histology and Nephrotic Syndrome GN1 AdrianLiew Chair SingaporeMount Elizabeth Novena Hospital, Singapore SuceenaAlexander Chair IndiaChristian Medical College Vellore Approach to Nephrotic Syndrome GN1-01 SuceenaAlexander Speaker IndiaChristian Medical College Vellore Case Presentation and Discussion 1 GN1-02 HeatherReich Speaker CanadaUniversity of Toronto, University Health Network Case Presentation and Discussion 2 GN1-03 Raja Ramachandran Speaker IndiaAssociate Professor Gulmohar Hall 302
11:30 a.m. 1:30 p.m.	Glomerular Disease Course - A Case-Based Approach: Nephritic Syndrome GN2 AdrianLiew Chair SingaporeMount Elizabeth Novena Hospital, Singapore SuceenaAlexander Chair IndiaChristian Medical College Vellore Approach to Nephritic Syndrome GN2-01 AdrianLiew Speaker SingaporeMount Elizabeth Novena Hospital, Singapore Case Presentation and Discussion 3 GN2-02 Jonathan Barret Speaker jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Case Presentation and Discussion 4 GN2-03 LizLightstone Speaker United KingdomImperial College London Case Presentation and Discussion 5 GN2-04 SuceenaAlexander Speaker IndiaChristian Medical College Vellore Gulmohar Hall 302
2:15 p.m. 4:15 p.m.	Glomerular Disease Course: Case-based Approach to Rapidly Progressive Glomerulonephritis and Glomerular Diseases in Acute Kidney Injury GN3 AdrianLiew Chair SingaporeMount Elizabeth Novena Hospital, Singapore SuceenaAlexander Chair IndiaChristian Medical College Vellore Approach to Rapidly Progressive Glomerulonephritis GN3-01 Raja Ramachandran Speaker IndiaAssociate Professor Case Presentation and Discussion 6 GN3-02 HernánTrimarchi Speaker ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Case Presentation and Discussion 7 GN3-03 Muh GeotWong Speaker Australia Case Presentation and Discussion 8 GN3-04 AdrianLiew Speaker SingaporeMount Elizabeth Novena Hospital, Singapore Gulmohar Hall 302